Dr. Lal PathLabs Limited (LALPATHLAB.BO)
INR 2797.0
(1.1%)
INR 2797.0
(1.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.26 Billion INR | 10.4% |
| 2022 | 20.16 Billion INR | -3.38% |
| 2021 | 20.87 Billion INR | 32.02% |
| 2020 | 15.81 Billion INR | 18.85% |
| 2019 | 13.3 Billion INR | 10.55% |
| 2018 | 12.03 Billion INR | 13.86% |
| 2017 | 10.56 Billion INR | 15.84% |
| 2016 | 9.12 Billion INR | 15.3% |
| 2015 | 7.91 Billion INR | 19.97% |
| 2014 | 6.59 Billion INR | 18.22% |
| 2013 | 5.57 Billion INR | 23.53% |
| 2012 | 4.51 Billion INR | 31.98% |
| 2011 | 3.42 Billion INR | 44.23% |
| 2010 | 2.37 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6.01 Billion INR | 10.36% |
| 2024 Q2 | 6.6 Billion INR | 9.69% |
| 2023 FY | 22.26 Billion INR | 10.4% |
| 2023 Q3 | 5.38 Billion INR | -10.38% |
| 2023 Q2 | 6.01 Billion INR | 11.15% |
| 2023 Q1 | 5.41 Billion INR | 10.18% |
| 2023 Q4 | 5.45 Billion INR | 1.21% |
| 2022 Q2 | 5.33 Billion INR | 6.19% |
| 2022 Q4 | 4.91 Billion INR | 0.33% |
| 2022 FY | 20.16 Billion INR | -3.38% |
| 2022 Q3 | 4.89 Billion INR | -8.32% |
| 2022 Q1 | 5.02 Billion INR | 3.57% |
| 2021 Q1 | 6.06 Billion INR | 40.75% |
| 2021 FY | 20.87 Billion INR | 32.02% |
| 2021 Q4 | 4.85 Billion INR | -2.32% |
| 2021 Q2 | 4.98 Billion INR | -17.84% |
| 2021 Q3 | 4.96 Billion INR | -0.3% |
| 2020 Q3 | 4.52 Billion INR | 4.75% |
| 2020 Q1 | 2.66 Billion INR | -11.82% |
| 2020 Q2 | 4.31 Billion INR | 62.37% |
| 2020 Q4 | 4.3 Billion INR | -4.74% |
| 2020 FY | 15.81 Billion INR | 18.85% |
| 2019 Q4 | 3.01 Billion INR | -8.0% |
| 2019 Q3 | 3.27 Billion INR | -10.31% |
| 2019 Q2 | 3.65 Billion INR | 9.07% |
| 2019 FY | 13.3 Billion INR | 10.55% |
| 2019 Q1 | 3.35 Billion INR | 11.32% |
| 2018 Q4 | 3.01 Billion INR | 2.95% |
| 2018 Q2 | 3.17 Billion INR | 8.62% |
| 2018 Q1 | 2.92 Billion INR | 9.56% |
| 2018 FY | 12.03 Billion INR | 13.86% |
| 2018 Q3 | 2.92 Billion INR | -7.87% |
| 2017 Q2 | 2.78 Billion INR | 11.55% |
| 2017 Q4 | 2.66 Billion INR | 1.56% |
| 2017 Q1 | 2.49 Billion INR | 13.37% |
| 2017 FY | 10.56 Billion INR | 15.84% |
| 2017 Q3 | 2.62 Billion INR | -5.54% |
| 2016 Q4 | 2.19 Billion INR | 5.98% |
| 2016 FY | 9.12 Billion INR | 15.3% |
| 2016 Q2 | 2.62 Billion INR | 17.68% |
| 2016 Q1 | 2.22 Billion INR | 12.69% |
| 2016 Q3 | 2.07 Billion INR | -20.86% |
| 2015 Q1 | 1.89 Billion INR | 10.14% |
| 2015 Q3 | 1.88 Billion INR | -12.59% |
| 2015 Q4 | 1.97 Billion INR | 4.85% |
| 2015 FY | 7.91 Billion INR | 19.97% |
| 2015 Q2 | 2.15 Billion INR | 13.96% |
| 2014 FY | 6.59 Billion INR | 18.22% |
| 2014 Q4 | 1.71 Billion INR | 10.31% |
| 2014 Q3 | 1.55 Billion INR | 0.0% |
| 2013 FY | 5.57 Billion INR | 23.53% |
| 2012 FY | 4.51 Billion INR | 31.98% |
| 2011 FY | 3.42 Billion INR | 44.23% |
| 2010 FY | 2.37 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 6.19 Billion INR | -259.326% |
| Metropolis Healthcare Limited | 12.07 Billion INR | -84.358% |
| Thyrocare Technologies Limited | 5.71 Billion INR | -289.33% |
| Vijaya Diagnostic Centre Limited | 5.47 Billion INR | -306.44% |
| Vimta Labs Limited | 3.18 Billion INR | -599.584% |